NeuPath Health

NeuPath Health Net Debt/Equity

The Net Debt to Equity Ratio of NeuPath Health (NPTH.V) as of Nov 4, 2026 is 0.27. In the previous year, Net Debt to Equity Ratio was 0.25 — a change of 8.55% (higher).

Net Debt/Equity

0.27

YoY

8.55%

Last updated:

Net Debt to Equity Ratio of NeuPath Health is 2025 0.27 . Net Debt to Equity Ratio of NeuPath Health was 2024 0.25 . It decreases by 8.55% higher compared to the previous year.

The NeuPath Health Net Debt/Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt/Equity
Date
Net Debt/Equity
Jan 1, 2019
0.55 CAD
Jan 1, 2020
0.18 CAD
Jan 1, 2021
0.19 CAD
Jan 1, 2022
0.17 CAD
Jan 1, 2023
0.25 CAD
Jan 1, 2025
0.27 CAD
The NeuPath Health Net Debt/Equity history
YEARNet Debt/EquityYoY
0.27+8.55%
0.25+46.36%
0.17-12.19%
0.19+8.01%
0.18-67.90%
0.55—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

NeuPath Health Stock analysis

What does NeuPath Health do? NeuPath Health, Inc. generates revenue through chronic pain management services provided at its clinics in Ontario and Alberta, offering comprehensive assessments and rehabilitation for chronic pain, musculoskeletal/back injuries, sports injuries, and concussions. The company serves employers and disability insurers with workplace health services and independent medical assessments via a national network of healthcare providers. Additionally, NeuPath provides contract research services to pharmaceutical and biotechnology companies. Its healthcare providers include physiatrists, neurologists, anesthesiologists, general practitioners with specialized pain training, medication management physicians, athletic therapists, and nurses. The primary buyers of NeuPath's services are employers and disability insurers seeking workplace health solutions and independent medical evaluations. Pharmaceutical and biotechnology companies contract NeuPath for research services. The company's clinic services target patients with chronic pain conditions, while its research division serves the pharmaceutical industry. NeuPath's network spans Ontario and Alberta, with a focus on specialized medical expertise across multiple disciplines. NeuPath Health, Inc. operates a network of medical clinics delivering chronic pain management and rehabilitation services. Its national provider network supports workplace health and independent medical assessments for employers and disability insurers. The firm's contract research division works with pharmaceutical and biotechnology companies, leveraging its medical expertise in pain management and rehabilitation. The company's service mix combines direct patient care with specialized industry contracts, creating multiple revenue streams from healthcare providers and corporate clients. NeuPath Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about NeuPath Health stock

Net Debt to Equity Ratio of NeuPath Health is 0.27 in 2025.

Net Debt to Equity Ratio of NeuPath Health changed from 0.25 to 0.27, representing a 8.55% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Debt to Equity Ratio NeuPath Health since 2006 – with annual values, charts, and detailed analysis.

Net Debt/Equity adjusts the debt-to-equity ratio by subtracting cash from total debt. It provides a more accurate picture of actual leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Debt to Equity Ratio's NeuPath Health with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — NeuPath Health

All Key Metrics — NeuPath Health